Loading...
RHK logo

RHÖN-KLINIKUM AktiengesellschaftXTRA:RHK Stock Report

Market Cap €823.3m
Share Price
€12.30
€12.5
1.6% undervalued intrinsic discount
1Y0%
7D-3.1%
1D
Portfolio Value
View

RHÖN-KLINIKUM Aktiengesellschaft

XTRA:RHK Stock Report

Market Cap: €823.3m

RHÖN-KLINIKUM (RHK) Stock Overview

Provides in-patient, semi-patient, and outpatient healthcare services in Germany. More details

RHK fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends2/6

RHK Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

RHÖN-KLINIKUM Aktiengesellschaft Competitors

Price History & Performance

Summary of share price highs, lows and changes for RHÖN-KLINIKUM
Historical stock prices
Current Share Price€12.30
52 Week High€13.40
52 Week Low€11.20
Beta-0.0025
1 Month Change-0.81%
3 Month Change-3.15%
1 Year Change0%
3 Year Change-2.38%
5 Year Change-22.45%
Change since IPO375.96%

Recent News & Updates

Analysis Article Apr 02

RHÖN-KLINIKUM's (ETR:RHK) Conservative Accounting Might Explain Soft Earnings

Soft earnings didn't appear to concern RHÖN-KLINIKUM Aktiengesellschaft's ( ETR:RHK ) shareholders over the last week...

Recent updates

Analysis Article Apr 02

RHÖN-KLINIKUM's (ETR:RHK) Conservative Accounting Might Explain Soft Earnings

Soft earnings didn't appear to concern RHÖN-KLINIKUM Aktiengesellschaft's ( ETR:RHK ) shareholders over the last week...
Analysis Article Dec 18

Is RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Trading At A 21% Discount?

Key Insights The projected fair value for RHÖN-KLINIKUM is €16.63 based on 2 Stage Free Cash Flow to Equity Current...
Analysis Article Aug 16

RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Jun 11

RHÖN-KLINIKUM (ETR:RHK) Is Doing The Right Things To Multiply Its Share Price

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Analysis Article Mar 01

RHÖN-KLINIKUM (ETR:RHK) Is Looking To Continue Growing Its Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Analysis Article Jan 08

Some Shareholders Feeling Restless Over RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) P/E Ratio

With a price-to-earnings (or "P/E") ratio of 23.6x RHÖN-KLINIKUM Aktiengesellschaft ( ETR:RHK ) may be sending bearish...
Analysis Article Jun 26

RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't

With a median price-to-earnings (or "P/E") ratio of close to 17x in Germany, you could be forgiven for feeling...
Analysis Article Apr 25

RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Mar 02

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

RHÖN-KLINIKUM Aktiengesellschaft ( ETR:RHK ) shareholders would be excited to see that the share price has had a great...
Analysis Article Dec 19

Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Jul 13

Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jun 15

There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Analysis Article Sep 20

These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Aug 11

Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Apr 01

Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)

Despite posting some strong earnings, the market for RHÖN-KLINIKUM Aktiengesellschaft's ( ETR:RHK ) stock hasn't moved...
Analysis Article May 14

Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

RHKDE HealthcareDE Market
7D-3.1%-4.0%-0.8%
1Y0%-19.1%2.3%

Return vs Industry: RHK exceeded the German Healthcare industry which returned -19.1% over the past year.

Return vs Market: RHK underperformed the German Market which returned 2.3% over the past year.

Price Volatility

Is RHK's price volatile compared to industry and market?
RHK volatility
RHK Average Weekly Movement3.5%
Healthcare Industry Average Movement6.4%
Market Average Movement6.1%
10% most volatile stocks in DE Market13.2%
10% least volatile stocks in DE Market2.7%

Stable Share Price: RHK has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: RHK's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197319,184n/awww.rhoen-klinikum-ag.com

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary

How do RHÖN-KLINIKUM's earnings and revenue compare to its market cap?
RHK fundamental statistics
Market cap€823.34m
Earnings (TTM)€40.05m
Revenue (TTM)€2.00b
20.6x
P/E Ratio
0.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHK income statement (TTM)
Revenue€2.00b
Cost of Revenue€1.79b
Gross Profit€208.87m
Other Expenses€168.81m
Earnings€40.05m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Aug 06, 2026

Earnings per share (EPS)0.60
Gross Margin10.43%
Net Profit Margin2.00%
Debt/Equity Ratio8.2%

How did RHK perform over the long term?

See historical performance and comparison

Dividends

1.6%
Current Dividend Yield
34%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/02 00:12
End of Day Share Price 2026/06/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RHÖN-KLINIKUM Aktiengesellschaft is covered by 18 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard SchwarzBaader Helvea Equity Research
Thomas JonesBerenberg
Julien DormoisBNP Paribas